Pemigatinib
| Pemigatinib | |
|---|---|
| Term | Pemigatinib |
| Short definition | Pemigatinib - (pronounced) (PEH-mih-GA-tih feather) drug used to treat adults with certain types of cholangiocarcinoma (bile duct cancer), myeloid cancer, or lymphatic cancer that have certain changes in the structure of the FGFR1 gene or FGFR2 gene. It is also being studied in the treatment of other types of cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Pemigatinib - (pronounced) (PEH-mih-GA-tih feather) drug used to treat adults with certain types of cholangiocarcinoma (bile duct cancer), myeloid cancer, or lymphatic cancer that have certain changes in the structure of the FGFR1 gene or FGFR2 gene. It is also being studied in the treatment of other types of cancer. Pemigatinib blocks a protein called FGFR, which can help prevent cancer cells from growing and kill them. It's a type of tyrosine kinase inhibitor. Also called pemazyres
External links
- Medical encyclopedia article on Pemigatinib
- Wikipedia's article - Pemigatinib
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski